Bioforce Nanosciences Holdings annual ebitda
2022
2023
2024
2025
Bioforce Nanosciences Holdings EBITDA Growth & History (BFNH)
Bioforce Nanosciences Holdings's calculated EBITDA was −$489,951 for fiscal 2025.
View full Bioforce Nanosciences Holdings company overviewBioforce Nanosciences Holdings annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$489,951 | $486 | — |
| 2024 | 2024-12-31 | −$490,437 | −$18,484 | — |
| 2023 | 2023-12-31 | −$471,953 | $13,561 | — |
| 2022 | 2022-12-31 | −$485,514 | — | — |
Bioforce Nanosciences Holdings quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$262,330 | −$139,549 | — |
| Q1 2026 | 2026-03-31 | −$117,733 | $15,724 | — |
| Q4 2025 | 2025-12-31 | −$117,798 | — | — |
| Q3 2025 | 2025-09-30 | −$115,915 | — | — |
| Q2 2025 | 2025-06-30 | −$122,781 | — | — |
| Q1 2025 | 2025-03-31 | −$133,457 | — | — |
Bioforce Nanosciences Holdings ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Bioforce Nanosciences Holdings's ebitda decreased from −$485,514 to −$489,951, a change of −$4,437. The latest reported quarter, Q2 2026, shows −$262,330.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioforce Nanosciences Holdings source filings ↗